SCHEMBL1807400

SCHEMBL1807400

CCOc1cc(OC)cc2ncnc(NCc3cc(S(N)(=O)=O)ccc3OCC(F)(F)F)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 9/20 0.55
BRAF P15056 8/20 0.55
LMNA P02545 4/20 0.38
SRC P12931 1/20 0.36
USP2 O75604 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CYP2C9 P11712 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
AURKA O14965 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1808559 0.94 TNNI3K (0.62) TNNI3KBRAFLMNASRCUSP2
Hydrochloric Acid SCHEMBL1804254 0.93 TNNI3K (0.61) TNNI3KBRAFLMNASRCUSP2
SCHEMBL1807965 0.91 TNNI3K (0.46) TNNI3KBRAFLMNASRCUSP2
SCHEMBL1809500 0.85 BRAF (0.53) TNNI3KBRAFLMNASRCUSP2
SCHEMBL1807652 0.84 TNNI3K (0.52) TNNI3KBRAFLMNASRCUSP2
SCHEMBL1805724 0.84 BRAF (0.63) TNNI3KBRAFLMNACA2MAPK1
SCHEMBL1807903 0.84 BRAF (0.63) TNNI3KBRAFLMNACA2MAPK1
SCHEMBL1806484 0.84 TNNI3K (0.58) TNNI3KBRAFCA2MAPK1ALDH1A1
Hydrochloric Acid SCHEMBL1804960 0.81 BRAF (0.49) TNNI3KBRAFLMNASRCUSP2
SCHEMBL1806158 0.81 BRAF (0.61) TNNI3KBRAFLMNACA2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed